ZNTL
#3275
Zentalis Pharmaceuticals, Inc. - common stock
4.4 2 USD
-0.02%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-1.78%
Variación mensual
+20.11%
Variación en los últimos 6 meses
+52.94%
Cambio anual
+194.67%
Cierres anteriores
4.5 0
Open
4.5 2
Mínimo
4.4 1
High
4.5 2
Volumen
186
Financials
- Market Capitalization 314.64 M
- Employee 106
- Founded 2014
- CEO N/A
- Website www.zentalis.com
- Headquarter California, United States
- FIGI BBG00R2K8TF5
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-1.34
Relación precio/flujo de caja
411.04
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3220 |  CTNM Contineum Therapeutics, Inc. - Common stock | 14.35 USD | -2.58% | +2.43% | +20.28% | -6.02% | 331.47 M USD | ||
| 3254 |  VNDA Vanda Pharmaceuticals Inc. - Common Stock | 5.35 USD | 0.00% | -1.83% | -10.39% | -3.25% | 321.73 M USD | ||
| 3295 |  INDP Indaptus Therapeutics, Inc. - Common Stock | 2.75 USD | +3.77% | +8.70% | -28.76% | +44.74% | 311.42 M USD | ||
| 3305 |  PRLD Prelude Therapeutics Incorporated - Common Stock | 3.81 USD | -3.05% | -9.72% | -12.61% | +314.13% | 303.45 M USD |